Venus Medtech (Hangzhou) VMTHF Stock
Venus Medtech (Hangzhou) Price Chart
Venus Medtech (Hangzhou) VMTHF Financial and Trading Overview
| Venus Medtech (Hangzhou) stock price | 0.39 USD |
| Previous Close | 1.86 USD |
| Open | 1.86 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.86 - 1.86 USD |
| 52 Week Range | 1.66 - 1.95 USD |
| Volume | 52K USD |
| Avg. Volume | 0 USD |
| Market Cap | 820.28M USD |
| Beta (5Y Monthly) | 0.304415 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VMTHF Valuation Measures
| Enterprise Value | -141851760 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.018099 |
| Price/Book (mrq) | 0.22575554 |
| Enterprise Value/Revenue | -0.349 |
| Enterprise Value/EBITDA | 0.24 |
Trading Information
Venus Medtech (Hangzhou) Stock Price History
| Beta (5Y Monthly) | 0.304415 |
| 52-Week Change | 12.04% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.95 USD |
| 52 Week Low | 1.66 USD |
| 50-Day Moving Average | 1.86 USD |
| 200-Day Moving Average | 1.78 USD |
VMTHF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 441.01M |
| Float | 255.5M |
| Short Ratio | N/A |
| % Held by Insiders | 21.67% |
| % Held by Institutions | 42.15% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -260.22% |
| Operating Margin (ttm) | -165.37% |
| Gross Margin | 77.25% |
| EBITDA Margin | -145.44% |
Management Effectiveness
| Return on Assets (ttm) | -8.085% |
| Return on Equity (ttm) | -27.15% |
Income Statement
| Revenue (ttm) | 406.46M USD |
| Revenue Per Share (ttm) | 0.93 USD |
| Quarterly Revenue Growth (yoy) | 11.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -591193984 USD |
| Net Income Avi to Common (ttm) | -1057699008 USD |
| Diluted EPS (ttm) | -0.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.88B USD |
| Total Cash Per Share (mrq) | 4.29 USD |
| Total Debt (mrq) | 899.64M USD |
| Total Debt/Equity (mrq) | 24.78 USD |
| Current Ratio (mrq) | 5.017 |
| Book Value Per Share (mrq) | 8.239 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -729459008 USD |
| Levered Free Cash Flow (ttm) | -559419648 USD |
Profile of Venus Medtech (Hangzhou)
| Country | United States |
| State | N/A |
| City | Hangzhou |
| Address | No. 88, Jiangling Road |
| ZIP | 310051 |
| Phone | 86 57 1877 72180 |
| Website | https://www.venusmedtech.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 1028 |
Venus Medtech (Hangzhou) Inc. engages in the research, development, clinical development, manufacturing, and commercialization of transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; transcatheter mitral and tricuspid valve replacement products; Liwen RF ablation system for the treatment of hypertrophic cardiomyopathy; and renal denervation for the treatment of hypertension. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.
Q&A For Venus Medtech (Hangzhou) Stock
What is a current VMTHF stock price?
Venus Medtech (Hangzhou) VMTHF stock price today per share is 0.39 USD.
How to purchase Venus Medtech (Hangzhou) stock?
You can buy VMTHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Venus Medtech (Hangzhou)?
The stock symbol or ticker of Venus Medtech (Hangzhou) is VMTHF.
Which industry does the Venus Medtech (Hangzhou) company belong to?
The Venus Medtech (Hangzhou) industry is Medical Devices.
How many shares does Venus Medtech (Hangzhou) have in circulation?
The max supply of Venus Medtech (Hangzhou) shares is 440.95M.
What is Venus Medtech (Hangzhou) Price to Earnings Ratio (PE Ratio)?
Venus Medtech (Hangzhou) PE Ratio is now.
What was Venus Medtech (Hangzhou) earnings per share over the trailing 12 months (TTM)?
Venus Medtech (Hangzhou) EPS is -0.22 USD over the trailing 12 months.
Which sector does the Venus Medtech (Hangzhou) company belong to?
The Venus Medtech (Hangzhou) sector is Healthcare.